Answers are grounded in this paper and cite their sources.
Introduction Receptor-based whole-cell biosensors convert molecular inputs into transcriptional outputs, but adjusting their sensitivity usually requires iterative redesign of promoters, ribosome-binding sites, receptor-expression levels, or plasmid architectures. Here, we investigated whether recombinase-mediated DNA excision could be used to preconfigure biosensor sensitivity before exposure to the target analyte. Methods Using a LuxR-based 3-oxo-C6-HSL-responsive circuit as a model system, we placed LuxR expression under the control of a transcriptional terminator flanked by Bxb1 recombination sites. Bxb1 expression was transiently induced with arabinose to generate programmed DNA-state distributions, after which arabinose was removed and the biosensor response to 3-oxo-C6-HSL was measured under inducer-free conditions. A direct arabinose-inducible LuxR circuit was used as a control to distinguish DNA-state programming from transient receptor induction. Results Arabinose-dependent Bxb1 induction generated distinct programmed sensor states that produced different 3-oxo-C6-HSL dose–response curves after removal of the programming inducer. Across the programmed configurations, the apparent E C 50 decreased by 7.8-fold, indicating that a single genetic architecture could be preconfigured to operate across different sensitivity regimes. In contrast, transient direct induction of LuxR did not produce a retained sensitivity shift after arabinose removal, whereas continuous arabinose induction altered the response. The Bxb1-programmed state persisted over one operational culture cycle but relaxed toward the basal state after further propagation. Discussion These results show that recombinase-mediated DNA-state modification can temporally decouple biosensor configuration from biosensor operation. The system does not behave as a permanently fixed memory device, but rather as a finite-retention architecture in which multicopy plasmid dynamics generate a transiently retained functional phenotype. This strategy provides a modular approach for producing preconfigured biosensor panels from a single genetic design.
No takes yet. Share an insight, caveat, or question.
Planell-Pozo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: